Regenova Pharmaceuticals Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 5

Regenova Pharmaceuticals General Information

Description

Operator of an antibody-drug discovery engine intended to accelerate the development of safe and effective biologic therapies for cancer and infectious diseases. The company offers an artificial intelligence (AI)-driven pipeline that predicts antibody-antigen binding and immunogenicity from sequence data, designs novel antibodies, and supports multiple stages of drug development from discovery to preclinical development, enabling pharmaceutical companies and research institutions to cut development time, reduce discovery costs, and bring new therapies faster under resource-efficient processes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Dover, DE
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • Dover, DE
  • United States

Regenova Pharmaceuticals Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Regenova Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 18-Dec-2025 Completed Pre-Clinical Trials
4. Accelerator/Incubator 12-Mar-2025 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2025 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2025 $12K $12K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
To view Regenova Pharmaceuticals’s complete valuation and funding history, request access »

Regenova Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Regenova Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
LvlUp Ventures Accelerator/Incubator Minority
Peachscore Accelerator/Incubator
Johns Hopkins University University
National Science Foundation Innovation Corps Program Accelerator/Incubator
H7 BioCapital Venture Capital Minority
To view Regenova Pharmaceuticals’s complete investors history, request access »

Regenova Pharmaceuticals FAQs

  • When was Regenova Pharmaceuticals founded?

    Regenova Pharmaceuticals was founded in 2023.

  • Where is Regenova Pharmaceuticals headquartered?

    Regenova Pharmaceuticals is headquartered in Dover, DE.

  • What is the size of Regenova Pharmaceuticals?

    Regenova Pharmaceuticals has 2 total employees.

  • What industry is Regenova Pharmaceuticals in?

    Regenova Pharmaceuticals’s primary industry is Discovery Tools (Healthcare).

  • Is Regenova Pharmaceuticals a private or public company?

    Regenova Pharmaceuticals is a Private company.

  • What is Regenova Pharmaceuticals’s current revenue?

    The current revenue for Regenova Pharmaceuticals is .

  • How much funding has Regenova Pharmaceuticals raised over time?

    Regenova Pharmaceuticals has raised $12K.

  • Who are Regenova Pharmaceuticals’s investors?

    LvlUp Ventures, Peachscore, Johns Hopkins University, National Science Foundation Innovation Corps Program, and H7 BioCapital have invested in Regenova Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process